DuPont's Innohep Anticoagulant Approved With Once-Daily Dosing Regimen
Executive Summary
DuPont's low molecular weight heparin Innohep will enter the market as the only treatment with once-daily dosing for all patients with deep vein thrombosis. Other LMWHs have a mix of recommended dosages, which may include once-daily administration.